Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-02-16

FDA Approved: FLUTICASONE PROPIONATE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved a supplemental application for Fluticasone Propionate submitted by Padagis Israel Pharmaceuticals Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone propionate (Fluticasone propionate)

Snippet

SUPPL AP for FLUTICASONE PROPIONATE (FLUTICASONE PROPIONATE)